Chronic Adverse Effects From Anti - PD - 1 Immunotherapies Common

About 43 percent of patients who receive anti - PD1 therapy for advanced melanoma have chronic immune - related adverse effects
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Dermatology, Oncology, Pharmacy, Journal, Source Type: news